857 results on '"Madonna, Rosalinda"'
Search Results
2. Pulmonary hypertension associated to left heart disease: Phenotypes and treatment
3. Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension
4. Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
5. Inferior vena cava filters: Concept review and summary of current guidelines
6. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
7. Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time
8. Endothelial heterogeneity and their relevance in cardiac development and coronary artery disease
9. Antineoplastic drugs inducing cardiac and vascular toxicity – An update
10. Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease
11. Editors’ Preamble to The Journal of Cardiovascular Aging
12. Biobanks: The unmet need in heart failure management
13. Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy
14. Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside
15. Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment
16. Angiocrine endothelium: From physiology to atherosclerosis and cardiac repair
17. Perspectives on Sotatercept in Pulmonary Arterial Hypertension.
18. Omega‐3 polyunsaturated fatty acids and pulmonary arterial hypertension: Insights and perspectives.
19. Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy
20. Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status
21. Exploring the mechanisms of action of gliflozines in heart failure and possible implications in pulmonary hypertension
22. Global position paper on cardiovascular regenerative medicine
23. Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?
24. Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
25. Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculoprotection in Personalized Therapy
26. Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair
27. Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism
28. Association of the European Society of Cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery
29. Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis
30. Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin
31. Stem Cell Therapies for Cardiac Regeneration: Current Burden—Future Directions
32. Tissue Specific Progenitors/Stem Cells for Cardiac Regeneration
33. Induced Pluripotent Stem Cells for Cardiac Regeneration
34. Biology and Function of Stem Cells
35. Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)
36. The Nutrigenetics of Cardiovascular Disease
37. Contributors
38. Cell based mechanosensing in vascular patho-biology: More than a simple go-with the flow
39. Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
40. Innate and adaptive immunity in atherosclerosis
41. Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology?
42. Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage
43. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens
44. Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death
45. Chronic thromboembolic disease: Association with exercise-induced pulmonary hypertension and right ventricle deterioration
46. Farmaci antineoplastici e tossicità cardiovascolare
47. Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study
48. Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”
49. Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to “Omics” Technologies
50. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.